These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25048195)

  • 21. Association of Genetic Variants Related to Gluteofemoral vs Abdominal Fat Distribution With Type 2 Diabetes, Coronary Disease, and Cardiovascular Risk Factors.
    Lotta LA; Wittemans LBL; Zuber V; Stewart ID; Sharp SJ; Luan J; Day FR; Li C; Bowker N; Cai L; De Lucia Rolfe E; Khaw KT; Perry JRB; O'Rahilly S; Scott RA; Savage DB; Burgess S; Wareham NJ; Langenberg C
    JAMA; 2018 Dec; 320(24):2553-2563. PubMed ID: 30575882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of 11β-hydroxysteroid dehydrogenase type 1 in visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with adiposity.
    Mlinar B; Marc J; Jensterle M; Bokal EV; Jerin A; Pfeifer M
    J Steroid Biochem Mol Biol; 2011 Feb; 123(3-5):127-32. PubMed ID: 21147223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity in effects of genetically determined adiposity on insulin resistance and type 2 diabetes: The atherosclerosis risk in communities study.
    Liu T; Li C; Shen L; Shen Y; Mao W; Li S
    J Diabetes Complications; 2018 Mar; 32(3):330-334. PubMed ID: 29395842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of susceptibility variants in ADIPOR1 gene associated with type 2 diabetes, coronary artery disease and the comorbidity of type 2 diabetes and coronary artery disease.
    Jin Z; Pu L; Sun L; Chen W; Nan N; Li H; Zhu H; Yang X; Wang N; Hui J; Zhang Y; Zhou Q; Zhao F; Yang F; Shi X; Zhu X; Yang Y; Zhang W; Zheng C; Li X; Yang D; Jia R; Meng S; Yang Z
    PLoS One; 2014; 9(6):e100339. PubMed ID: 24967709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The rs822396 Polymorphism of the
    Rubio-Chavez LA; Rosales-Gomez RC; Rubio-Chavez KL; Ramos-Nuñez JL; Garcia-Cobian TA; Camargo-Hernandez G; Sanchez-Corona J; Gutierrez-Rubio SA
    Metab Syndr Relat Disord; 2020 Jun; 18(5):243-250. PubMed ID: 32159445
    [No Abstract]   [Full Text] [Related]  

  • 26. Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant.
    Palmer CN; Maglio C; Pirazzi C; Burza MA; Adiels M; Burch L; Donnelly LA; Colhoun H; Doney AS; Dillon JF; Pearson ER; McCarthy M; Hattersley AT; Frayling T; Morris AD; Peltonen M; Svensson PA; Jacobson P; Borén J; Sjöström L; Carlsson LM; Romeo S
    PLoS One; 2012; 7(6):e39362. PubMed ID: 22724004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
    Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
    Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations of irs-1 polymorphism with various components of the metabolic syndrome in hypertensive patients.
    Kochuieva M; Psarova V; Ruban L; Kyrychenko N; Alypova O; Matlai O; Shalimova A
    Wiad Lek; 2019 Aug; 72(8):1484-1498. PubMed ID: 32003208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes.
    Utzschneider KM; Van de Lagemaat A; Faulenbach MV; Goedecke JH; Carr DB; Boyko EJ; Fujimoto WY; Kahn SE
    Obesity (Silver Spring); 2010 Sep; 18(9):1781-7. PubMed ID: 20379148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abdominal fat depots and their association with insulin resistance in patients with type 2 diabetes.
    Garg UK; Mathur N; Sahlot R; Tiwari P; Sharma B; Saxena A; Jainaw RK; Agarwal L; Gupta S; Mathur SK
    PLoS One; 2023; 18(12):e0295492. PubMed ID: 38064530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variants primarily associated with type 2 diabetes are related to coronary artery disease risk.
    Jansen H; Loley C; Lieb W; Pencina MJ; Nelson CP; Kathiresan S; Peloso GM; Voight BF; Reilly MP; Assimes TL; Boerwinkle E; Hengstenberg C; Laaksonen R; McPherson R; Roberts R; Thorsteinsdottir U; Peters A; Gieger C; Rawal R; Thompson JR; König IR; ; Vasan RS; Erdmann J; Samani NJ; Schunkert H
    Atherosclerosis; 2015 Aug; 241(2):419-26. PubMed ID: 26074316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Classification of Type 2 Diabetes Genetic Variants and a Novel Genetic Risk Score Association With Insulin Clearance.
    Goodarzi MO; Palmer ND; Cui J; Guo X; Chen YI; Taylor KD; Raffel LJ; Wagenknecht LE; Buchanan TA; Hsueh WA; Rotter JI
    J Clin Endocrinol Metab; 2020 Apr; 105(4):1251-60. PubMed ID: 31714576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comprehensive investigation of variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/R2), and their association with serum adiponectin, type 2 diabetes, insulin resistance and the metabolic syndrome.
    Peters KE; Beilby J; Cadby G; Warrington NM; Bruce DG; Davis WA; Davis TM; Wiltshire S; Knuiman M; McQuillan BM; Palmer LJ; Thompson PL; Hung J
    BMC Med Genet; 2013 Jan; 14():15. PubMed ID: 23351195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study.
    Neeland IJ; Singh S; McGuire DK; Vega GL; Roddy T; Reilly DF; Castro-Perez J; Kozlitina J; Scherer PE
    Diabetologia; 2018 Dec; 61(12):2570-2579. PubMed ID: 30159588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Variants of the
    Aljaibeji H; Mohammed AK; Alkayyali S; Hachim MY; Hasswan H; El-Huneidi W; Taneera J; Sulaiman N
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32570874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bivariate genome-wide scan for metabolic phenotypes in non-diabetic Chinese individuals from the Stanford, Asia and Pacific Program of Hypertension and Insulin Resistance Family Study.
    Chiu YF; Chuang LM; Kao HY; Ho LT; Ting CT; Hung YJ; Chen YD; Donlon T; Curb JD; Quertermous T; Hsiung CA
    Diabetologia; 2007 Aug; 50(8):1631-40. PubMed ID: 17579830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum C-X-C motif chemokine ligand 14 levels are associated with serum C-peptide and fatty liver index in type 2 diabetes mellitus patients.
    Matsushita Y; Hasegawa Y; Takebe N; Onodera K; Shozushima M; Oda T; Nagasawa K; Honma H; Nata K; Sasaki A; Ishigaki Y
    J Diabetes Investig; 2021 Jun; 12(6):1042-1049. PubMed ID: 33063457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mendelian randomization studies do not support a role for raised circulating triglyceride levels influencing type 2 diabetes, glucose levels, or insulin resistance.
    De Silva NM; Freathy RM; Palmer TM; Donnelly LA; Luan J; Gaunt T; Langenberg C; Weedon MN; Shields B; Knight BA; Ward KJ; Sandhu MS; Harbord RM; McCarthy MI; Smith GD; Ebrahim S; Hattersley AT; Wareham N; Lawlor DA; Morris AD; Palmer CN; Frayling TM
    Diabetes; 2011 Mar; 60(3):1008-18. PubMed ID: 21282362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Implications for syndrome X.
    Gaillard TR; Schuster DP; Bossetti BM; Green PA; Osei K
    Diabetes Care; 1997 May; 20(5):745-52. PubMed ID: 9135936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.